Rusalatide

N/A

Report date: 2023/09/27 17:48:02
NME

Base Information

Drug NameRusalatide
Drug Alias NameThrombin receptor activating peptideRusalatide acetateChrysalinTRAP-508TP-508
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionProtease-activated receptor-1 agonistsProtease-activated receptor-3 agonistsProtease-activated receptor-4 agonists +[10] 
TargetsProtease-activated receptor-1Protease-activated receptor-3Protease-activated receptor-4 +[5] 
Therapy Area/IndicationsRadius FracturesRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of MedicineUniversity Of Texas Medical Branch
China Registration ClassN/A

Develop Information

Active CompaniesChrysalis BioTherapeutics Inc
Inactive CompaniesCapstone Therapeutics Corp
Active IndicationsRespiratory Distress Syndrome, Adult
Inactive IndicationsRadius Fractures

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG